Erica F Weiss1, David Masur2, Shlomo Shinnar3, Dale C Hesdorffer4, Veronica J Hinton5, Melanie Bonner6, Julie Rinaldi7, Virginia Van de Water8, James Culbert9, Ruth C Shinnar2, Syndi Seinfeld10, William Gallentine11, Douglas R Nordli12, L Mathew Frank8, Leon Epstein13, Solomon L Moshé14, Shumei Sun15. 1. Department of Neurology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, United States. Electronic address: eweiss@montefiore.org. 2. Department of Neurology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, United States. 3. Department of Neurology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, United States; Department of Pediatrics, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, United States; Department of Epidemiology and Population Health, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, United States. 4. GH Sergievsky Center, Columbia University, New York, NY, United States; Department of Epidemiology, Columbia University, New York, NY, United States. 5. GH Sergievsky Center, Columbia University, New York, NY, United States; Department of Neurology, Columbia University, New York, NY, United States. 6. Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC, United States. 7. Department of Psychiatry and Behavioral Sciences, Northwestern University, Feinberg School of Medicine, Chicago, IL, United States. 8. Department of Neurology, Children's Hospital of The King's Daughters and Eastern Virginia Medical School, Norfolk, VA, United States; Department of Pediatrics, Children's Hospital of The King's Daughters and Eastern Virginia Medical School, Norfolk, VA, United States. 9. Department of Neurology, Medical College of Virginia, Virginia Commonwealth University, Richmond, VA, United States; Department of Psychiatry, Medical College of Virginia, Virginia Commonwealth University, Richmond, VA, United States. 10. Department of Neurology, Medical College of Virginia, Virginia Commonwealth University, Richmond, VA, United States. 11. Department of Pediatrics-Neurology, Duke University Medical Center, Durham, NC, United States. 12. Department of Neurology, Children's Hospital of Los Angeles, United States. 13. Department of Neurology, Ann & Robert H. Lurie Children's Hospital of Chicago, United States. 14. Department of Neurology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, United States; Department of Pediatrics, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, United States; Department of Neuroscience, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, United States. 15. Department of Biostatistics, Medical College of Virginia, Virginia Commonwealth University, Richmond, VA, United States.
Abstract
OBJECTIVE: The objective of this study was to determine early developmental and cognitive outcomes of children with febrile status epilepticus (FSE) one month and one year after FSE. METHODS: One hundred ninety four children with FSE were evaluated on measures of cognition, receptive language, and memory as part of the FEBSTAT study and compared with 100 controls with simple febrile seizures (FSs). RESULTS: Children with FSE did not differ dramatically on tasks compared with FS controls at one month after FSE but demonstrated slightly weaker motor development (p=0.035) and receptive language (p=0.034) at one year after FSE. Performances were generally within the low average to average range. Within the FSE cohort, non-White children performed weaker on many of the tasks compared with Caucasian children. At the one-year visit, acute hippocampal T2 findings on MRI were associated with weaker receptive language skills (p=0.0009), and human herpes virus 6 or 7 (HHV6/7) viremia was associated with better memory performances (p=0.047). CONCLUSION: Febrile status epilepticus does not appear to be associated with significant cognitive impairment on early developmental measures, although there is a trend for possible receptive language and motor delay one year after FSE. Further follow-up, which is in progress, is necessary to track long-term cognitive functioning.
OBJECTIVE: The objective of this study was to determine early developmental and cognitive outcomes of children with febrile status epilepticus (FSE) one month and one year after FSE. METHODS: One hundred ninety four children with FSE were evaluated on measures of cognition, receptive language, and memory as part of the FEBSTAT study and compared with 100 controls with simple febrile seizures (FSs). RESULTS:Children with FSE did not differ dramatically on tasks compared with FS controls at one month after FSE but demonstrated slightly weaker motor development (p=0.035) and receptive language (p=0.034) at one year after FSE. Performances were generally within the low average to average range. Within the FSE cohort, non-White children performed weaker on many of the tasks compared with Caucasian children. At the one-year visit, acute hippocampal T2 findings on MRI were associated with weaker receptive language skills (p=0.0009), and human herpes virus 6 or 7 (HHV6/7) viremia was associated with better memory performances (p=0.047). CONCLUSION:Febrile status epilepticus does not appear to be associated with significant cognitive impairment on early developmental measures, although there is a trend for possible receptive language and motor delay one year after FSE. Further follow-up, which is in progress, is necessary to track long-term cognitive functioning.
Authors: James M Provenzale; Daniel P Barboriak; Kevan VanLandingham; James MacFall; David Delong; Darrell V Lewis Journal: AJR Am J Roentgenol Date: 2008-04 Impact factor: 3.959
Authors: Dale C Hesdorffer; Shlomo Shinnar; Darrell V Lewis; Solomon L Moshé; Douglas R Nordli; John M Pellock; James MacFall; Ruth C Shinnar; David Masur; L Matthew Frank; Leon G Epstein; Claire Litherland; Syndi Seinfeld; Jacqueline A Bello; Stephen Chan; Emilia Bagiella; Shumei Sun Journal: Epilepsia Date: 2012-06-28 Impact factor: 5.864
Authors: J A French; P D Williamson; V M Thadani; T M Darcey; R H Mattson; S S Spencer; D D Spencer Journal: Ann Neurol Date: 1993-12 Impact factor: 10.422
Authors: Michelle L Kloc; Dylan H Marchand; Gregory L Holmes; Rachel D Pressman; Jeremy M Barry Journal: Epilepsy Behav Date: 2021-12-10 Impact factor: 2.937
Authors: Michelle L Kloc; Jennifer M Daglian; Gregory L Holmes; Tallie Z Baram; Jeremy M Barry Journal: Epilepsia Date: 2021-09-25 Impact factor: 5.864
Authors: Marina M Martinos; Suresh Pujar; Christopher Gillberg; Mario Cortina-Borja; Brian G R Neville; Michelle De Haan; Rod C Scott; Richard F M Chin Journal: Dev Med Child Neurol Date: 2017-12-10 Impact factor: 5.449
Authors: Barbara C Jobst; Elinor Ben-Menachem; Kevin E Chapman; Aradia Fu; Alica Goldman; Lawrence J Hirsch; Lara E Jehi; Eric H Kossoff; Madona Plueger; Jong M Rho; Catherine A Schevon; Shlomo Shinnar; Michael R Sperling; Timothy A Simeone; Janelle L Wagner; Fred Lado Journal: Epilepsy Curr Date: 2019-05-03 Impact factor: 7.500
Authors: Marina M Martinos; Suresh Pujar; Helen O'Reilly; Michelle de Haan; Brian G R Neville; Rod C Scott; Richard F M Chin Journal: Epilepsy Behav Date: 2019-04-19 Impact factor: 2.937